#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3644	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2130	494.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1773	1773	T	532	T,G	446,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3644	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2130	494.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1507	1507	C	551	C	462	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3644	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2130	494.7	0	HET	.	.	.	C751T	.	751	751	C	1074	1074	C	593	C,T	279,201	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3644	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2130	494.7	0	HET	.	.	.	A69G	.	69	69	A	392	392	A	492	A,G	217,188	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3850	504.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1824	1824	A	545	A	449	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3850	504.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2458	2458	C	589	C	479	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3850	504.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2532	2532	A	640	A	516	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3850	504.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3084	3084	C	564	C,G	450,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	624	folP	852	852	99.88	folP.l15.c4.ctg.1	1798	103.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	887	889	AAA	155;156;157	A,C;A;A,C	128,2;131;126,2	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	624	folP	852	852	99.88	folP.l15.c4.ctg.1	1798	103.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1118	1120	AGC	147;147;148	A,C;G;C	111,1;116;113	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1168	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3760	92.9	1	SNP	p	S91F	0	.	.	271	273	TCC	713	715	TCC	93;92;92	T;C,A;C	75;76,1;77	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1168	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3760	92.9	1	SNP	p	D95N	0	.	.	283	285	GAC	725	727	GAC	92;92;93	G;A;C	77;75;79	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1168	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3760	92.9	1	SNP	p	D95G	0	.	.	283	285	GAC	725	727	GAC	92;92;93	G;A;C	77;75;79	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	548	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1555	104.7	1	SNP	p	G45D	0	.	.	133	135	GGC	617	619	GGC	147;147;147	G;G;C	120;118;117	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	268	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1299	61.7	0	.	n	.	0	A197.	DEL	197	197	A	694	694	A	122	A	88	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3130	123.3	1	SNP	p	D86N	0	.	.	256	258	GAC	602	604	GAC	158;157;158	G;A;C	133;122;128	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3130	123.3	1	SNP	p	S87R	0	.	.	259	261	AGT	605	607	AGT	157;157;157	A;G,C;T	125;131,1;122	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3130	123.3	1	SNP	p	S87I	0	.	.	259	261	AGT	605	607	AGT	157;157;157	A;G,C;T	125;131,1;122	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3130	123.3	1	SNP	p	S87W	0	.	.	259	261	AGT	605	607	AGT	157;157;157	A;G,C;T	125;131,1;122	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	1290	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3130	123.3	1	SNP	p	S88P	0	.	.	262	264	TCC	608	610	TCC	157;158;159	T;C;C	126;126;127	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1140	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2990	114.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1642	1644	GGC	145;142;142	G;G,T;C	115;111,1;114	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1365	1367	GCA	147;146;146	G,T;C;A	116,1;120;123	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1368	1370	ATC	147;146;145	A;T;C	121;114;124	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1380	1382	GTG	141;141;142	G;T;G,A	121;117;118,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1380	1382	GTG	141;141;142	G;T;G,A	121;117;118,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1884	1886	ACC	119;118;118	A;C;C	97;102;104	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1938	1940	GCG	117;115;116	G;C,G;G	96;89,1;94	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1938	1940	GCG	117;115;116	G;C,G;G	96;89,1;94	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2061	2063	GGC	120;120;120	G;G;C	99;98;98	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2070	2072	GGC	119;119;119	G;G;C,T	97;96;96,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	1030	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2647	116.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2088	2090	CTG	115;114;114	C;T;G	96;94;91	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1358	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3434	118.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1776	1778	CCG	108;108;108	C;C;G	79;82;81	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	720	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2115	101.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	719	719	C	113	C	91	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1173	1175	AAT	13;13;13	A;A;T	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1176	1178	AAT	13;13;13	A;A;T	10;10;9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1200	1202	GCA	13;13;13	G;C;A	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1223	1225	GTA	12;12;12	G;T;A	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	W235trunc	TRUNC	703	703	T	1226	1226	T	12	T	10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	S236N	NONSYN	706	708	AGC	1229	1231	AAC	12;12;12	A;A;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	.	MULTIPLE	709	711	AAC	1233	1237	TGGCG	12;11;11;11;11	T;G;G;C;G	10;10;10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	D238A	NONSYN	712	714	GAT	1239	1241	GCT	11;11;11	G;C;T	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	1299	1301	TTA	8;8;8	T;T;A	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	1344	1346	CAT	9;9;9	C;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	1347	1349	AGT	10;10;10	A;G;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	112	porB1a	984	297	90.03	porB1a.l15.c4.ctg.1	1445	22.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	1356	1358	TAC	10;10;10	T;A;C	8;8;8	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	565	567	GAA	161;161;160	G;A;A	127;128;127	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	853	855	GAT	157;158;158	G;A;T	118;120;122	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	976	978	TCA	156;155;154	T,G;C;A,C	122,1;123;121,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1105	1107	GTC	152;153;154	G;T;C,A	121;122;127,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	0	.	p	.	0	G255E	NONSYN	763	765	GGA	1216	1218	GAA	154;154;152	G;A;A	119;125;121	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1435	1437	GCA	148;148;148	G;C;A,G	116;120;114,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	1	SNP	p	G120K	1	.	.	358	360	AAG	811	813	AAG	150;149;149	A;A,C;G	115;115,1;115	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	1	SNP	p	D121N	0	.	.	361	363	GAC	814	816	GAC	149;151;150	G;A,C;CAA,CAAA	117;113,1;110,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	742	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1866	118.2	1	SNP	p	A121D	1	.	.	361	363	GAC	814	816	GAC	149;151;150	G;A,C;CAA,CAAA	117;113,1;110,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	2570	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5359	143.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2245	2247	AAT	134;134;134	A;A;T	113;109;112	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	380	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1247	90.6	1	SNP	p	V57M	1	.	.	169	171	ATG	607	609	ATG	166;165;165	A;T;G	129;130;126	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
